Document is current
Any future updates will be listed below
-
Authors
Puthanakit, Thanyawee
Prompetchara, Eakachai
Gatechompol, Sivaporn
Ketloy, Chutitorn
Thitithanyanont, Arunee
Jongkaewwattana, Anan
Buranapraditkun, Supranee
Ubolyam, Sasiwimol
Kerr, Stephen J.
Sophonphan, Jiratchaya
Apornpong, Tanakorn
Kittanamongkolchai, Wonngarm
Siwamogsatham, Sarawut
Sriplienchan, Somchai
Patarakul, Kanitha
Theerawit, Tuangtip
Promsena, Pathariya
Nantanee, Rapisa
Manomaisantiphap, Siwaporn
Chokyakorn, Sarun
Hong, Lina
Samija, Mijo
Montefiori, David C.
Gao, Hongmei
Eaton, Amanda
Wijagkanalan, Wassana
Alameh, Mohamad-Gabriel
Weissman, Drew
Ruxrungtham, Kiat
,
Tawan, Monta
Sutjarit, Aungsumalin
Meepuksom, Thutsanun
Athipunjapong, Jitthiwa
Jupimai, Thidarat
Moonwong, Juthamanee
Nadsasarn, Rachaneekorn
Khamthi, Sasiprapha
Nuncharoen, Pornpavee
Chanpoom, Yanisar
Khamkhen, Phattharapa
Narupan, Nirunya
Thongthip, Siriwan
Soisoongnern, Konsiri
Shanyip, Chomnid
Rachpradit, Thanakan
Sriphraram, Kanipha
Somhanwong, Wassana
Boondamnern, Timporn
Boonnak, Nittaya
Chomchey, Nitiya
Tipsuk, Somporn
Puttamaswin, Suwanna
Yewande, Siriyapat
Lertarom, Plengsri
Uanithirat, Anuntaya
Anuchadbut, Anongnart
Chanthaburanun, Sararut
Tarawat, Katawut
Mahanontharit, Apicha
Sinthon, Wanida
Plakunmonthonw, Sasitorn
Wongmueang, Suwat
Dalodom, Theera
Sopa, Bunruan
Phongam, Nuchthida
Sri-Arunsak, Anchisa
Chobkarching, Umaporn
Bouko, Channuwat
Junseeha, Sukanya
Phuphalicho, Boonsri
Pingthaisong, Palida
Khlaiphuengsin, Apichaya
Pararit, Patcharee
Eamyoung, Patcharin
Somjit, Thitiporn
Iampornsin, Thatri
Thongchomphunut, Dutmanee
Manopwisedjaroen, Suwimon
Laopanupong, Thanida
Ekronarongchai, Supanuch
Srisaowakarn, Chanya
Jantraphakorn, Yuparat
Srisutthisamphan, Kanjana
Grandin, Ponsuk Visudhipan
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04566276 at ClinicalTrials.govDocuments that mention this clinical trial
Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study
https://doi.org/10.1038/s41598-023-49653-6
-
Funding
Funding for this research was provided by:
Public Donation through Covid-19 vaccine development fund of the Faculty of Medicine, Chulalongkorn University and the Thai Red Cross Society, Thailand
National Vaccine Institute (2563.1/11)
The Ratchadapisek Sompoch Endowment Fund (2021), Chulalongkorn University (764002-HE04)
- License Information
-
More Information
Article History
Received: 2 August 2023
Accepted: 11 December 2023
First Online: 29 January 2024
Competing interests
: In accordance with the University of Pennsylvania policies and procedures and our ethical obligations as researchers, we report that D.W. and M.G.A are named on patents that describe the use of nucleoside-modified mRNA as a platform to deliver therapeutic proteins and vaccines. L.H and M.S. are employees of Genevant Sciences Corporation. W.W. is an employee of BioNet-Asia, Co. Ltd. We have disclosed those interests fully to the University of Pennsylvania, and we have in place an approved plan for managing any potential conflicts arising from licensing of our patents. The other authors declare no competing interests.
